Archive for October 11th, 2011

Clinical trial updates for BPAX and OMER

Oct 11, 2011 No Comments by

Omeros Corporation (NASDAQ: OMER) said today that it expects data from its first double-blind, placebo-controlled trial of OMS302 in intra-ocular lens replacement surgery, to be released during 1Q 2012. This compares with earlier guidance of a data release duirng 1H 2012. BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), announced today that the independent Data Monitoring Committee (DMC) […]

Daily News Read more